Elevated serum macrophage inhibitory factor-related protein (MRP) 8/14 levels in advanced HIV infection and during disease exacerbation

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 4, 1997, Pages 230-238

  Strasser, Florian ^a,b   Gowland, Peter L ^a   Ruef, Christian ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute phase proteins; Bacterial infection; Calprotectin; CD4+ lymphocyte count; Chemokine; Cytokine; HIV infection; Macrophage related proteins (MRP 8, MRP 14, MRP 8 14)

Indexed keywords

ACUTE PHASE PROTEIN; ANTIGEN P24; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CHEMOKINE; CYTOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR; VIRUS RNA;

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030844099     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199712010-00002     Document Type: Article

References (47)

1. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328: 327-5.
2. Saag MS. Evolving understanding of the immunopathogenesis of HIV. AIDS Res Hum Retroviruses 1994;10:887-92.
3. Volberding PS, Graham NM. Initiation of antiretroviral therapy in HIV infection: a review of interstudy consistencies. J AIDS 1994;7 (Suppl 2):S12-22.
4. +-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993;53:197-204.
5. Sorg C. The calcium binding proteins MRP8 and MRP14 in acute and chronic inflammation. Behring Inst Mitt 1992;91:126-137.
6. Brandtzaeg P, Gabrielsen TO, Dale I, Müller F, Steinbakk M, Fagerhol MK. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 1995;371A:201-6.
7. Dorin JR, Novak M, Hill RE, Brock DJH, Secher DS. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 1987,326:614-617.
8. Stockley RA, Dale I, Hill SL, Fagerhol MK. Relationship of neutrophil cytoplasmic protein (L1) to acute and chronic lung disease. Scand J Clin Lab Invest 1984;44:629-34.
9. Steinbakk M, Naess AC, Lingaase E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990;336:763-5.
10. Lugering GN, Stoll R, Kucharzik T, Burgmeister G, Sorg C, Domschke W. Serum 27E10 antigen: a new potential marker for staging HIV disease. Clin Exp Immunol 1995;101:249-53.
11. Hogg N, Allen C, Edgeworth J. Monoclonal antibody 5.5 reacts with p8,14, a myeloid molecule associated with some vascular endothelium. Eur J Immunol 1989;19:1053-61.
12. Brandtzaeg P, Dale I, Fagerhol M. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissue. Am J Clin Pathol 1987;87:700-7.
13. Lemarchand P, Vaglio M, Mauel J, Markert M. Translocation of a small cytosolic calcium binding protein (MRP-8) to plasma membrane correlates with human neutrophil activation. J Biol Chem 1992;267:19379-82.
14. Goebeler M, Roth J, Van-den-bos C, Ader G, Sorg C. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein (MRP8) and MRP14 to keratin intermediate filaments. Biochem J 1995;309(Pt 2):419-24.
15. Zwadlo G, Brueggen J, Gerhards G, Schlegel R, Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol 1988;72:510-15.
16. Goebeler M, Roth J, Henseleit U, Sunderkotter C, Sorg C. Expression and complex assembly of calcium-binding proteins MRP8 and MRP14 during differentiation of murine myelomonocytic cells. J Leukoc Biol 1993;53:11-18.
17. Roth J, Teigelkamp S, Wilke M, Grun L, Tummler B, Sorg C. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992;186:304-14.
18. Mori S, Goto K, Goto F, Murakami K, Ohkawara S, Yoshinaga M. Dynamic changes in mRNA expression of neutrophils during the course of acute inflammation in rabbits. Int Immunol 1994;6:149-56.
19. Burkhardt K, Bosnecker A, Hilebrand G, et al. MRP8/14-positive macrophages as early acute cellular rejection markers, and soluble MRP8/14 and increased expression of adhesion molecules following renal transplantation. Transplant Proc 1995;27:890-1.
20. Bhardwaj RS, Zotz C, Zwadlo G, et al. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur J Immunol 1992;22:1891-7.
21. Mahnke H, Bhardwaj R, Sorg C. Heterodimers of the calcium-binding proteins MRP8 and MRP14 are expressed on the surface of human monocytes upon adherence to fibronectin and collagen. Relation to TNF-alpha, IL-6, and superoxide production. J Leukoc Biol 1995;57:63-71.
22. Kuruto R, Nozawa R, Takeishi K, Arai K, Yokota T, Takasaki Y. Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. J Biochem 1990;108:650-3.
23. Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994;21:733-8.
24. Hammer HB, Kvien TK, Glenn AS A, Melby K. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin Exp Rheumatol 1995;13:59-64.
25. +)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 1995;56:406-14.
26. Lugering N, Stoll R, Schmid KW, et al. The myeloic related protein MRP8/14 (27E10 antigen)-usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest 1995;25:659-64.
27. Sander J, Fagerhol M, Bakken J, Dale I. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leukocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984;44:357-62.
28. Homann C, Garred P, Graudal N, et al. Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis. Hepatology 1995;21:979-85.
29. Miyasaki KT, Bodeau AL, Murthy AR, Lehrer RI. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena. J Dent Res 1993;72:517-23.
30. Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defense. Scand J Immunol 1995;42: 551-6.
31. Santhanagopalan V, Hahn BL, Dunn BE, Weissner JH, Sohnle PG. Antimicrobial activity of calprotectin isolated from human empyema fluid supernatants. CLIn Immunol Immunopathol 1995;76(3 Pt. 1):285-90.
32. Yui S, Mikami M, Yamazaki M. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. J Leukoc Biol 1995;58:650-8.
33. Brun JG, Ulvestad E, Fagerhol MK, Jonsson R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand J Immunol 1994;40:675-80.
34. Devery JM, King NJ, Geczy L. Acute inflammatory activity of the S100 protein CP-10. J Immunol 1994;152:1888-97.
35. Watt KW, Brightman IL, Goetzl EJ. Isolation of two polypeptides comprising the neutrophil-immobilizing factor of human leucocytes. Immunology 1983;48:79-86.
36. Freemont P, Hogg N, Edgeworth J. Sequence identity. Nature 1989,339:516.
37. Muller F, Froland SS, Aukrust P, Fagerhol MK. Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZVD treatment is associated with clinical events. J AIDS 1994;7:931-9.
38. Muller F, Froland SS, Brandtzaeg P, Fagerhol MK. Oral Ccandidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. Clin Infect Dis 1993;16:301-2.
39. Dunlop O, Bruun JN, Myrvang B, Fagerhol MK. Calprotectin in cerebrospinal fluid of the HIV infected: a diagnostic marker of opportunistic central nervous system infection? Scand J Infect Dis 1991;23:687-9.
40. Ledergerber B, Von Overbeck J, Egger M, Luethy R and the Swiss HIV Cohort Study (SHCS): The Swiss HIV cohort study: rationale, organization and selected baseline characteristics. Soz Präventivmed 1994;39:387-94.
41. Gan H, Ruef C, Hall BF, Tobin E, Remold HG, Mellors JW. Interleukin-6 expression in primary macrophages infected with human immunodeficiency virus-1 (HIV-1). AIDS Res Hum Retroviruses 1991;7:671-9.
42. Godfried MK, Van der poll T, Jansen J, et al. Soluble receptors for tumor necrosis factor: a putative marker of disease progression in HIV infection. AIDS 1993;7:33-6.
43. Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanism of HIV infection. Ann Intern Med 1996;124:654-63.
44. Mc Namara MO, Wiessner JH, Collins-Lech C, et al. Neutrophil death as a defence mechanism against Candida albicans infections. Lancet 1988;19:1163-5.
45. Murphy PM, Lane HC, Fauci AS, Gallin JI. Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 1988;158:627-30.
46. Ellis M, Gupta S, Galant S, et al. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis 1988;158:1268-76.
47. Cassone A, Palma C, Djeu JY, Aiuti F, Quinti I. Anticandidal activity and interleukin-1b and interleukin-6 production of polymorphonuclear leukocytes are preserved in subjects with AIDS. J Clin Microb 1993;31:1354-7.